Details of the Drug Reposition

General Information of This Drug (ID: DM5ONA9)

Drug Name
Cysteine Hydrochloride   DM5ONA9
Synonyms
DL-Cysteine hydrochloride; 10318-18-0; 2-amino-3-mercaptopropanoic acid hydrochloride; CYSTEINE HYDROCHLORIDE; H-DL-Cys-OH.HCl; (+-)-Cysteine hydrochloride; DL-CYSTEINE HCL; CYSTEINE, HYDROCHLORIDE, DL-; EINECS 233-698-2; DL-Cysteine hydrochloride hydrate; NSC8746; DL-Cysteine hydrochloride anhydrous; MFCD00064552; 2-amino-3-sulfanylpropanoic acid hydrochloride; C-9675; DL-Cysteine hydrochloride, 95%, anhydrous; AK-73021; L-Cysteine, hydrochloride (1:1); Cysteine chlorohydrate; H-DL-Cys-OH Cl; L-Cystein-hydrochloride
Drug Type
Small molecular drug
Structure
3D MOL is unavailable 2D MOL

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)
4 Approved Indication(s)
Indication Name Indication ID ICD-11 Status REF
Paracetamol poisoning DISJXZQF N.A. Approved [1]
Amyloidosis DISHTAI2 5D00 Approved [1]
Bronchitis DISBM6EQ CA20 Approved [1]
Bronchiectasis DIS5MYEE CA24 Approved [1]
------------------------------------------------------------------------------------
1 Discontinued in Phase 2 Indication(s)
Indication Name Indication ID ICD-11 Status REF
Adverse reactions to acetaminophen or acetaminophen overdose DISNQAJO PB24 Discontinued in Phase 2 [2]
------------------------------------------------------------------------------------

References

1 Cysteine Hydrochloride FDA Label
2 Effect of Glycine in Cystic Fibrosis